Switzerland Pharmaceuticals and Healthcare Report Q2 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Switzerland Pharmaceuticals and Healthcare Report Q2 2013 May 8th 2013, 00:00 BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI believes the government needs to do more to alter patients'' attitudestowards these drugs as this is the main growth deterrent.Headline Expenditure Projections? Pharmaceuticals: CHF6.58bn (US$7.02bn) in 2012 to CHF6.44bn (US$6.27bn) in 2013; -2.1% declinein local currency terms.? Healthcare: CHF67.60bn (US$72.11bn) in 2012 to CHF69.71bn (US$67.89bn) in 2013; +3.1% growthin local currency terms....

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions